Leharso, Noralyn S.

HRN: 21-23-89  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/14/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
04/14/2022
04/21/2022
IV
500
Q8
PROPHYLAXIS

 Indication:  Prophylaxis    Type of Infection:  Prophylaxis    Compliance to guidelines: Non-compliant To Guidelines